US Stock MarketDetailed Quotes

NEO NeoGenomics

Watchlist
  • 16.410
  • +0.010+0.06%
Close Dec 20 16:00 ET
  • 16.510
  • +0.100+0.61%
Post 20:01 ET
2.11BMarket Cap-26.90P/E (TTM)

About NeoGenomics Company

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Company Profile

SymbolNEO
Company NameNeoGenomics
Listing DateDec 10, 2012
Founded1998
CEOMr. Christopher M. Smith
MarketNASDAQ
Employees2100
Fiscal Year Ends12-31
Address9490 NeoGenomics Way
CityFort Myers
ProvinceFlorida
CountryUnited States of America
Zip Code33912
Phone1-239-768-0600

Company Executives

  • Name
  • Position
  • Salary
  • Christopher M. Smith
  • Chief Executive Officer and Director
  • 11.67M
  • Warren Stone
  • Chief Commercial Officer
  • 3.01M
  • Jeffrey S. Sherman
  • Chief Financial Officer
  • 3.55M
  • Gregory D. Aunan
  • Chief Accounting Officer
  • --
  • Cynthia J. Dieter
  • Chief Accounting Officer and Controller
  • --
  • Melody Harris
  • Chief Operations Officer and President, Informatics
  • 4.69M
  • Alicia C. Olivo
  • Executive Vice President, Business Development, General Counsel and Corporate Secretary
  • --
  • Lynn A. Tetrault, J.D.
  • Chairman of the Board
  • 365.00K
  • Vishal Sikri
  • President, Advanced Diagnostics
  • 2.37M
  • Felicia Williams
  • Director
  • --
  • Dr. Neil Gunn
  • Independent Director
  • 276.31K
  • Elizabeth A. Floegel
  • Independent Director
  • 273.39K
  • Stephen M. Kanovsky
  • Independent Director
  • 309.20K
  • Anthony P. Zook
  • Independent Director
  • 276.31K
  • Dr. Alison L. Hannah, M.D.
  • Independent Director
  • 65.00K
  • David B. Perez
  • Independent Director
  • 309.80K
  • Michael A. Kelly
  • Independent Director
  • 317.50K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.